In this issue:
Rituximab vs cyclosporine for membranous nephropathy
Timing of dialysis initiation in Canada after the IDEAL trial
A new risk-prediction tool for IgA nephropathy
PICCs in patients with advanced CKD
NSAID use and risk of AKI and hyperkalaemia in older adults
Fatigue in patients with nondialysis CKD
Restrictive vs liberal approach to red blood cell transfusion in cardiac surgery patients
Renal effects of empagliflozin in patients with type 2 diabetes
Mycophenolate mofetil vs cyclophosphamide in ANCA-associated vasculitis
Risk of ESKD in older live kidney donors with hypertension
Please login below to download this issue (PDF)